Sara Bonstein - 07 Jan 2025 Form 4 Insider Report for INSMED Inc (INSM)

Signature
/s/ Sara Bonstein, by Michael A. Smith as Attorney-in-fact
Issuer symbol
INSM
Transactions as of
07 Jan 2025
Net transactions value
-$392,602
Form type
4
Filing time
10 Jan 2025, 18:45:26 UTC
Previous filing
17 Jun 2024
Next filing
07 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Sale $227,979 -3,470 -2.9% $65.70 114,736 07 Jan 2025 Direct F1, F2, F3
transaction INSM Common Stock Sale $96,697 -1,464 -1.3% $66.05 113,272 08 Jan 2025 Direct F1
transaction INSM Common Stock Award +6,657 +5.9% 119,929 08 Jan 2025 Direct F4, F5
transaction INSM Common Stock Sale $67,926 -1,066 -0.89% $63.72 118,863 10 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Award $0 +31,930 $0.000000 31,930 08 Jan 2025 Common Stock 31,930 $65.72 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
F2 This is the weighted average sales price representing 3,470 shares sold at prices ranging from $65.69 to $65.72 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3 Includes 725 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
F4 Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
F5 Each RSU was granted on January 8, 2025 for no consideration.
F6 These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.